Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FT204
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,159
Award facts
- Contract value 100% obligated
- $25,158.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitive, non-set-aside contract carries a ceiling value of $25,158.51 and utilizes firm fixed pricing, with performance to be completed by November 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military and federal healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical supplies. The DLA's Pharmaceutical Prime Vendor Global Program is expected to establish Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen as a key provider within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FT204?
SPE2DR26FT204 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FT204 worth?
The government has obligated $25,159 on SPE2DR26FT204.
Is contract SPE2DR26FT204 an order under another contract?
Yes. SPE2DR26FT204 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT204 competed?
The extent of competition for SPE2DR26FT204 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award